Carolyn H. McCabe

54.2k total citations · 19 hit papers
182 papers, 38.6k citations indexed

About

Carolyn H. McCabe is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Carolyn H. McCabe has authored 182 papers receiving a total of 38.6k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Cardiology and Cardiovascular Medicine, 81 papers in Surgery and 58 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Carolyn H. McCabe's work include Acute Myocardial Infarction Research (109 papers), Cardiac Imaging and Diagnostics (58 papers) and Coronary Interventions and Diagnostics (48 papers). Carolyn H. McCabe is often cited by papers focused on Acute Myocardial Infarction Research (109 papers), Cardiac Imaging and Diagnostics (58 papers) and Coronary Interventions and Diagnostics (48 papers). Carolyn H. McCabe collaborates with scholars based in United States, United Kingdom and Canada. Carolyn H. McCabe's co-authors include Christopher P. Cannon, Eugene Braunwald, Elliott M. Antman, Eugene Braunwald, Sabina A. Murphy, David A. Morrow, C. Michael Gibson, Stephen D. Wiviott, Marc S. Sabatine and Gilles Montalescot and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Carolyn H. McCabe

180 papers receiving 36.8k citations

Hit Papers

Prasugrel versus Clopidogrel in Pa... 1979 2026 1994 2010 2007 2004 2000 2005 1996 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
    2007 4.4k citations Stephen D. Wiviott, Eugene Braunwald et al. New England Journal of Medicine profile →
  2. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
    2004 3.4k citations Christopher P. Cannon, Eugene Braunwald et al. New England Journal of Medicine profile →
  3. The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
    2000 2.3k citations Carolyn H. McCabe, Ramón Corbalán et al. profile →
  4. C-Reactive Protein Levels and Outcomes after Statin Therapy
    2005 1.7k citations Paul M. Ridker, Christopher P. Cannon et al. New England Journal of Medicine profile →
  5. TIMI Frame Count
    1996 1.5k citations C. Michael Gibson, Christopher P. Cannon et al. Circulation profile →
  6. Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation
    2005 1.3k citations Marc S. Sabatine, C. Michael Gibson et al. New England Journal of Medicine profile →
  7. Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes
    1996 1.3k citations Elliott M. Antman, Milenko J. Tanasijevic et al. New England Journal of Medicine profile →
  8. TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation
    2000 1.1k citations David A. Morrow, Elliott M. Antman et al. Circulation profile →
  9. The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes
    2001 991 citations James A. de Lemos, David A. Morrow et al. New England Journal of Medicine profile →
  10. Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction
    1999 729 citations Elliott M. Antman, Carolyn H. McCabe et al. Circulation profile →
  11. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
    2009 669 citations Gilles Montalescot, Stephen D. Wiviott et al. The Lancet profile →
  12. Relationship of TIMI Myocardial Perfusion Grade to Mortality After Administration of Thrombolytic Drugs
    2000 648 citations C. Michael Gibson, Christopher P. Cannon et al. Circulation profile →
  13. Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
    2007 623 citations Stephen D. Wiviott, Andrew L. Frelinger et al. Circulation profile →
  14. C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy
    1998 599 citations David A. Morrow, Nader Rifai et al. Journal of the American College of Cardiology profile →
  15. Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes
    2002 557 citations Marc S. Sabatine, David A. Morrow et al. Circulation profile →
  16. Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes
    2005 539 citations Marc S. Sabatine, David A. Morrow et al. Circulation profile →
  17. Diabetes and Mortality Following Acute Coronary Syndromes
    2007 511 citations Carolyn H. McCabe, Sabina A. Murphy et al. profile →
  18. Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
    2008 498 citations Stephen D. Wiviott, Eugene Braunwald et al. Circulation profile →
  19. Exercise Stress Testing
    1979 427 citations Donald A. Weiner, Thomas J. Ryan et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carolyn H. McCabe United States 80 29.7k 17.3k 9.7k 5.1k 3.0k 182 38.6k
Frans Van de Werf Belgium 97 29.8k 1.0× 11.9k 0.7× 9.8k 1.0× 4.1k 0.8× 2.6k 0.9× 779 38.8k
Elliott M. Antman United States 108 49.4k 1.7× 17.3k 1.0× 11.3k 1.2× 9.6k 1.9× 3.9k 1.3× 527 61.0k
Harvey D. White New Zealand 99 45.2k 1.5× 21.6k 1.2× 14.0k 1.4× 5.8k 1.1× 3.8k 1.3× 719 57.9k
Joseph S. Alpert United States 67 37.7k 1.3× 11.9k 0.7× 12.0k 1.2× 4.3k 0.8× 4.2k 1.4× 348 48.1k
Eugene Braunwald United States 104 43.0k 1.4× 20.7k 1.2× 12.5k 1.3× 4.5k 0.9× 4.2k 1.4× 448 59.7k
Keith A.A. Fox United Kingdom 109 47.7k 1.6× 15.5k 0.9× 11.2k 1.2× 12.1k 2.4× 4.8k 1.6× 834 59.8k
Sabina A. Murphy United States 97 30.0k 1.0× 17.9k 1.0× 6.4k 0.7× 5.8k 1.1× 3.3k 1.1× 487 43.5k
Maarten L. Simoons Netherlands 77 22.8k 0.8× 9.8k 0.6× 8.8k 0.9× 2.5k 0.5× 2.9k 1.0× 355 29.8k
Pierre Théroux Canada 74 19.0k 0.6× 10.2k 0.6× 6.4k 0.7× 3.1k 0.6× 1.2k 0.4× 273 26.4k
Lars Wallentin Sweden 114 49.4k 1.7× 14.3k 0.8× 7.5k 0.8× 15.1k 3.0× 5.6k 1.9× 753 59.3k

Countries citing papers authored by Carolyn H. McCabe

Since Specialization
Citations

This map shows the geographic impact of Carolyn H. McCabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolyn H. McCabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolyn H. McCabe more than expected).

Fields of papers citing papers by Carolyn H. McCabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolyn H. McCabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolyn H. McCabe. The network helps show where Carolyn H. McCabe may publish in the future.

Co-authorship network of co-authors of Carolyn H. McCabe

This figure shows the co-authorship network connecting the top 25 collaborators of Carolyn H. McCabe. A scholar is included among the top collaborators of Carolyn H. McCabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolyn H. McCabe. Carolyn H. McCabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scirica, Benjamin M., David A. Morrow, Christoph Bode, et al.. (2010). Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial. European Heart Journal. 31(16). 1993–2005. 38 indexed citations
2.
Frelinger, Andrew L., Alan D. Michelson, Eugene Braunwald, et al.. (2008). Abstract 3994: Pharmacodynamic Assessment of Platelet Inhibition by Prasugrel versus Clopidogrel in the TRITON-TIMI 38 Trial. Circulation. 118. 2 indexed citations
3.
Wiviott, Stephen D., Eugene Braunwald, Dominick J. Angiolillo, et al.. (2008). Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38. Circulation. 118(16). 1626–1636. 498 indexed citations breakdown →
4.
5.
Wiviott, Stephen D., Eugene Braunwald, Carolyn H. McCabe, et al.. (2007). Prasugrel versus clopidogrel in patients with acute coronary syndromes: Commentary. Revista Portuguesa de Pneumologia. 26(11). 1297–1298. 2 indexed citations
6.
Wiviott, Stephen D., Eugene Braunwald, Carolyn H. McCabe, et al.. (2007). Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes. New England Journal of Medicine. 357(20). 2001–2015. 4421 indexed citations breakdown →
7.
Gibson, C. Michael, Sabina A. Murphy, Carolyn H. McCabe, et al.. (2006). Abstract 3288: Association of Treatment with Non-Steroidal Anti-Inflammatory Agents (NSAIDS) on Study Entry with 30 Day Adverse Outcomes Among ST Elevation MI (STEMI) Patients Treated with a Fibrinolytic Agent. An EXTRACT-TIMI 25 Analysis. Circulation. 114. 3 indexed citations
8.
9.
Ridker, Paul M., Christopher P. Cannon, David A. Morrow, et al.. (2005). C-Reactive Protein Levels and Outcomes after Statin Therapy. New England Journal of Medicine. 352(1). 20–28. 1708 indexed citations breakdown →
10.
Wiviott, Stephen D., David A. Morrow, Frederick A. Spencer, et al.. (2004). Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4. Journal of the American College of Cardiology. 44(4). 783–789. 74 indexed citations
11.
Sabatine, Marc S., David A. Morrow, James A. de Lemos, et al.. (2004). Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. Journal of the American College of Cardiology. 44(10). 1988–1995. 272 indexed citations
12.
Bahit, Maria Cecilia, Elliott M. Antman, Sabina A. Murphy, Carolyn H. McCabe, & Christopher P. Cannon. (2002). Comparison of characteristics, treatment, and outcomes of patients enrolled versus not enrolled in a clinical trial: findings from TIMI 9 Registry and 9b trial. Journal of the American College of Cardiology. 39. 303–303. 1 indexed citations
13.
Lemos, James A. de, David A. Morrow, C. Michael Gibson, et al.. (2002). The prognostic value of serum myoglobin in patients with non–ST-segment elevation acute coronary syndromes. Journal of the American College of Cardiology. 40(2). 238–244. 34 indexed citations
14.
Cannon, Christopher P., Peter Sharis, Marc J. Schweiger, et al.. (1997). Prospective Validation of a Composite End Point in Thrombolytic Trials of Acute Myocardial Infarction (TIMI 4 and 5). The American Journal of Cardiology. 80(6). 696–699. 15 indexed citations
15.
Cannon, Christopher P., Carolyn H. McCabe, Peter H. Stone, et al.. (1997). Circadian Variation in the Onset of Unstable Angina and Non-Q-Wave Acute Myocardial Infarction (The TIMI III Registry and TIMI IIIB). The American Journal of Cardiology. 79(3). 253–258. 99 indexed citations
16.
Cannon, Christopher P., Carolyn H. McCabe, Timothy D. Henry, et al.. (1994). A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. Journal of the American College of Cardiology. 23(5). 993–1003. 180 indexed citations
17.
Safian, Robert D., Carolyn H. McCabe, Mary Ellen Sipperly, Raymond G. McKay, & Donald S. Baim. (1988). Initial success and long-term follow-up of percutaneous transluminal coronary angioplasty in chronic total occlusions versus conventional stenoses. The American Journal of Cardiology. 61(14). 23G–28G. 121 indexed citations
18.
Alderman, James, Gregory Gabliani, Carolyn H. McCabe, et al.. (1987). Incidence and management of limb ischemia with percutaneous wire-guided intraaortic balloon catheters. Journal of the American College of Cardiology. 9(3). 524–530. 67 indexed citations
19.
Faxon, David P., Katherine M. Detre, Carolyn H. McCabe, et al.. (1984). Role of percutaneous transluminal coronary angioplasty in the treatment of unstable angina. The American Journal of Cardiology. 53(12). C131–C135. 80 indexed citations
20.
Weiner, Donald A., et al.. (1983). Efficacy and safety of incremental doses of diltiazem for the treatment of stable angina pectoris. Journal of the American College of Cardiology. 2(6). 1129–1133. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frans Van de Werf Breakdown of academic impact, for papers by Elliott M. Antman Breakdown of academic impact, for papers by Harvey D. White Breakdown of academic impact, for papers by Joseph S. Alpert Breakdown of academic impact, for papers by Eugene Braunwald Breakdown of academic impact, for papers by Keith A.A. Fox Breakdown of academic impact, for papers by Sabina A. Murphy Breakdown of academic impact, for papers by Maarten L. Simoons Breakdown of academic impact, for papers by Pierre Théroux Breakdown of academic impact, for papers by Lars Wallentin
Rankless by CCL
2026